Overview
- Editors:
-
-
Terumi Kamisawa
-
Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Bunkyo-ku, Tokyo, Japan
-
Myung-Hwan Kim
-
Department of Internal Medicine, ASAN Medical Center, Seoul, Korea (Republic of)
Illustrates imaging features on all relevant modalities
Describes differential diagnosis from other diseases
Discusses current and emerging therapeutic strategies
Access this book
Other ways to access
Table of contents (22 chapters)
-
Front Matter
Pages i-viii
-
- Takahiro Nakazawa, Shuya Simizu, Tadashi Toyohara, Hiromichi Araki, Katumi Hayashi
Pages 1-7
-
-
-
-
-
- Tetsuya Ito, Takayuki Watanabe, Takashi Muraki, Shigeyuki Kawa
Pages 39-44
-
- Hirotaka Ohara, Itaru Naitoh, Kazuki Hayashi, Katsuyuki Miyabe, Takahiro Nakazawa
Pages 45-50
-
- Hisato Igarashi, Testuhide Ito, Kosei Ishigami, Masayuki Hijioka, Hirotaka Ohara
Pages 51-55
-
-
- Atsushi Kanno, Atsushi Masamune, Tooru Shimosegawa
Pages 63-70
-
- Itaru Naitoh, Takahiro Nakazawa, Hirotaka Ohara, Takashi Joh
Pages 71-77
-
- Sung-Hoon Moon, Myung-Hwan Kim
Pages 79-85
-
- Kensuke Kubota, Akito Iwasaki, Takamitsu Sato, Kunihiro Hosono
Pages 87-94
-
-
- Satomi Koizumi, Terumi Kamisawa, Sawako Kuruma, Kazuro Chiba, Masataka Kikuyama
Pages 99-104
-
- Hee Seung Lee, Seungmin Bang
Pages 105-107
-
- Kazushige Uchida, Kazuichi Okazaki
Pages 109-112
-
- Shounak Majumder, Mark D. Topazian
Pages 113-118
-
- Takeshi Kuwada, Masahiro Shiokawa, Teruko Tomono, Norimitsu Uza, Yuzo Kodama
Pages 119-124
About this book
This book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.
Editors and Affiliations
-
Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Bunkyo-ku, Tokyo, Japan
Terumi Kamisawa
-
Department of Internal Medicine, ASAN Medical Center, Seoul, Korea (Republic of)
Myung-Hwan Kim
About the editors
Terumi Kamisawa, MD, PhD, AGAF, is a gastroenterologist who specializes in pancreatobiliary disease. He became deputy director of Tokyo Metropolitan Komagome Hospital in 2015. Dr. Kamisawa gained a Master’s degree and PhD from Hirosaki University School of Medicine, Aomori, Japan, in 1982 and 1995, respectively. He became an executive board member of the Japan Biliary Association in 2011 and of the Japan Pancreas Society in 2012. Since 2007 he has been an associate editor of Pancreas and Journal of the Pancreas. He is an editorial board member of the Journal of Gastroenterology, the Journal of Hepatobiliary Pancreatic Sciences, and Gut and Liver.
Myung-Hwan Kim, MD, PhD, is a gastroenterologist with a special interest in pancreatobiliary disease. He is a professor at University of Ulsan College of Medicine and Director of the Pancreatobiliary Center at the Asan Medical Center. He is a former president of the Korean Pancreatobiliary Association and also of the Korean Society of Gastrointestinal Endoscopy. He is now a Council member of both the International Association of Pancreatology (IAP) and the Asian Oceanic Pancreatic Association (AOPA).
